Tracing the Anti-cancer Mechanism of Pleurotus osteratus by the Integrative Approach of Network Pharmacology and Experimental Studies

被引:8
作者
Shreya, Singh [1 ]
Kumar, Dulla Naveen [2 ]
Mohapatra, Debadatta [1 ]
Jaiswal, Shivani [3 ]
Naik, Gaurav Gopal [1 ]
Guru, Santosh Kumar [4 ]
Agarwal, Ashish Kumar [2 ]
Ayyannan, Senthil Raja [3 ]
Sahu, Alakh N. [1 ]
机构
[1] Indian Inst Technol BHU, Dept Pharmaceut Engn & Technol, Phytomed Res Lab, Varanasi 221005, Uttar Pradesh, India
[2] Indian Inst Technol BHU, Dept Pharmaceut Engn & Technol, Nanomed Res Lab, Varanasi 221005, Uttar Pradesh, India
[3] Indian Inst Technol BHU, Dept Pharmaceut Engn & Technol, Pharmaceut Chem Res Lab 2, Varanasi 221005, Uttar Pradesh, India
[4] NIPER Hyderabad, Dept Biol Sci, Dept Pharmaceut, Hyderabad 500037, Telangana, India
关键词
Anti-cancer; EAC bearing Swiss albino mice; Network pharmacology; PI3K-AKT-mTOR; Pleurotus osteratus; TAMOXIFEN RESISTANCE; RECEPTOR;
D O I
10.1007/s12010-022-04111-3
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The present study identified the probable mechanism behind the anti-cancer activity of the hexane fraction of Pleurotus osteratus (HFPO) using network pharmacology and experimental validation. HFPO myco-metabolites targets and targets related to the cancer were mined from the online web server, and overlapping targets were screened. Out of the 74 overlapping targets, 33 targets were identified in the Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway of cancer. Furthermore, the main active myco-metabolites and hub targets were identified by network analysis of the compound-targets network and protein-protein interaction (PPI), respectively. Molecular docking results showed good binding affinity of the hub targets with their respective myco-metabolites. HFPO induced in-vitro anti-cancer activity by affecting the PI3K-AKT-mTOR pathway, besides time-dependent cell cytotoxicity and apoptotic cell body formation. Additionally, tumor volume reduction was observed in HFPO-treated Ehrlich ascites carcinoma (EAC) bearing Swiss albino mice. Overall, HFPO induces anti-cancer potential by modulating the PI3K-AKT-mTOR signaling pathway.
引用
收藏
页码:152 / 171
页数:20
相关论文
共 50 条
[21]   Assessing the Anti-cancer Therapeutic Mechanism of a Herbal Combination for Breast Cancer on System-level by a Network Pharmacological Approach [J].
Lee, Ho-Sung ;
Oh, Dal-Seok .
ANTICANCER RESEARCH, 2020, 40 (09) :5097-5106
[22]   Study on Structure-Function Relationship of the Anti-inflammatory and Anti-cancer Effects of Catechins Using Cell Models and Network Pharmacology [J].
Ying S. ;
Lu S. ;
Chen Z. ;
Zhang Y. ;
Li B. ;
Lin X. .
Science and Technology of Food Industry, 2024, 45 (05) :18-29
[23]   Network pharmacology alliance with experimental validation unveils the anti-colorectal cancer mechanism of Xianlian Jiedu decoction [J].
Fan, Xiaoxuan ;
Yan, Qiuying ;
Xu, Weicheng ;
Chen, Hui ;
Xu, Yanru ;
Lu, Sicheng ;
Xu, Changliang ;
Tan, Jiani ;
Yu, Chengtao ;
Lai, Yueyang ;
Fan, Minmin ;
Tao, Lihuiping ;
Li, Liu ;
Shen, Weixing ;
Cheng, Haibo ;
Sun, Dongdong .
JOURNAL OF ETHNOPHARMACOLOGY, 2025, 342
[24]   Network Pharmacology Analysis of ZiShenWan for Diabetic Nephropathy and Experimental Verification of Its Anti-Inflammatory Mechanism [J].
Guo, Xiaoyuan ;
Wu, You ;
Zhang, Chengfei ;
Wu, Lili ;
Qin, Lingling ;
Liu, Tonghua .
DRUG DESIGN DEVELOPMENT AND THERAPY, 2021, 15 :1577-1594
[25]   A Network Pharmacology Approach to Investigate the Anti- Depressive Mechanism of Gardeniae fructus [J].
Xiao, Zhijun ;
Liu, Cuicui ;
Duan, Jingjing ;
Zhou, Ting ;
Liu, Xiufeng ;
Lu, Saihua ;
Xu, Feng .
INTERNATIONAL JOURNAL OF PHARMACOLOGY, 2020, 16 (05) :382-397
[26]   Elucidation of the underlying mechanism of Hua-ban decoction in alleviating acute lung injury by an integrative approach of network pharmacology and experimental verification [J].
Zhou, Wei ;
Hu, Zhuannan ;
Wu, Xianwei ;
Zhang, Shunxian ;
Jiang, Yuwei ;
Tian, Li ;
Huang, Xing ;
Ma, Zifeng ;
Qiu, Lei ;
Zheng, Peiyong ;
Zhang, Shaoyan ;
Lu, Zhenhui .
MOLECULAR IMMUNOLOGY, 2023, 156 :85-97
[27]   An Integrated Approach Using Network Pharmacology and Experimental Validation to Reveal the Therapeutic Mechanism of Weifuchun in Treating Gastric Cancer [J].
Wang, Ziyuan ;
Zhang, Zhipeng ;
Azami, Nisma Lena Bahaji ;
Hui, Dengcheng ;
Wang, Zheng ;
Xie, Dong ;
Ye, Guan ;
Liu, Ningning ;
Sun, Mingyu .
JOURNAL OF MEDICINAL FOOD, 2024, 27 (12) :1168-1182
[28]   Pharmacological potential of Clinacanthus nutans: integrating network pharmacology with experimental studies against lung cancer [J].
Marseti, Salma Wahid ;
Hermanto, Feri Eko ;
Widyananda, Muhammad Hermawan ;
Rosyadah, Nuraini ;
Kamila, Fairuz Sarah ;
Annisa, Yuslinda ;
Dwijayanti, Dinia Rizqi ;
Ulfa, Siti Mariyah ;
Widodo, Nashi .
JOURNAL OF BIOLOGICALLY ACTIVE PRODUCTS FROM NATURE, 2024, 14 (03) :343-358
[29]   Anti-colorectal cancer targets of resveratrol and biological molecular mechanism: Analyses of network pharmacology, human and experimental data [J].
Li, Rong ;
Ma, Xiuying ;
Song, Yingqi ;
Zhang, Yuanyuan ;
Xiong, Wenbi ;
Li, Li ;
Zhou, Liming .
JOURNAL OF CELLULAR BIOCHEMISTRY, 2019, 120 (07) :11265-11273
[30]   The mechanism of dioscin preventing lung cancer based on network pharmacology and experimental validation [J].
Xi, Peng ;
Niu, Yuji ;
Zhang, Yaru ;
Li, Wenwen ;
Gao, Fan ;
Gu, Wenwen ;
Kui, Fuguang ;
Liu, Zhongqiu ;
Lu, Linlin ;
Du, Gangjun .
JOURNAL OF ETHNOPHARMACOLOGY, 2022, 292